Daniel H. White Net Worth

The estimated Net Worth of Daniel H. White is at least $1.09 Milion dollars as of 28 March 2018. Daniel White owns over 11,000 units of Clearside Biomedical Inc stock worth over $633,169 and over the last 8 years Daniel sold CLSD stock worth over $452,522.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Daniel White CLSD stock SEC Form 4 insiders trading

Daniel has made over 9 trades of the Clearside Biomedical Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Daniel bought 11,000 units of CLSD stock worth $99,770 on 28 March 2018.

The largest trade Daniel's ever made was selling 16,000 units of Clearside Biomedical Inc stock on 7 September 2017 worth over $121,120. On average, Daniel trades about 4,786 units every 47 days since 2016. As of 28 March 2018 Daniel still owns at least 483,335 units of Clearside Biomedical Inc stock.

You can see the complete history of Daniel White stock trades at the bottom of the page.

What's Daniel White's mailing address?

Daniel's mailing address filed with the SEC is 900 North Point Pkwy # 200, Alpharetta, GA 30005, USA.

Insiders trading at Clearside Biomedical Inc

Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp a Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.

What does Clearside Biomedical Inc do?

clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.

Complete history of Daniel White stock trades at Clearside Biomedical Inc

Clearside Biomedical Inc executives and stock owners

Clearside Biomedical Inc executives and other stock owners filed with the SEC include:

• George Lasezkay,
  President, Chief Executive Officer, Director
• Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.,
  Pres, CEO & Director
• Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D.,
  Pres, CEO & Director
• Charles Deignan,
  Chief Financial Officer
• Dr. Thomas A. Ciulla M.B.A., M.D.,
  Chief Medical Officer & Chief Devel. Officer
• Charles A. Deignan,
  Chief Financial Officer
• Jenny Kobin,
  IR Contact Officer
• Clay Thorp,
  Independent Director
• Nancy Hutson,
  Independent Director
• William Humphries,
  Independent Director
• Jeffrey Edwards,
  Independent Director
• Richard Croarkin,
  Independent Director
• Christy Shaffer,
  Independent Chairman of the Board
• Susan L. Coultas Ph.D.,
  Chief Clinical Officer
• Rick McElheny,
  VP of Corp. Devel.
• Leslie B. Zacks,
  Gen. Counsel, Chief Compliance Officer & Sec.
• Jenny R. Kobin,
  Head of Investor Relations
• Venture Advisors Iii, Llc H...,
  
• Venture Advisors Iv Sbic, L...,
  
• Venture Advisors Iii, Llc H...,
  
• Evgeny Zaytsev,
  Director
• Daniel H. White,
  President and CEO
• Investments S.A.R.L.Rusnano...,
  
• Derek Yoon,
  Director
• Gerald D. Cagle,
  Director
• Venture Advisors Iv Sbic, L...,
  
• Glenn Noronha,
  Executive Vice President, R&D
• Thomas Ciulla,
  Chief Medical Officer
• Brion S. Raymond,
  Chief Commercial Officer
• Anthony S Gibney,
  
• Bradford T Whitmore,
  10% owner
• Ngai Hang Victor Chong,
  Chief Medical Officer
• Benjamin R Yerxa,